Corso-Restrepo DF, Solier Insuasty-Enríquez J, Oviedo-Pastrana DF, Anaya-Rodríguez AF

Language: Spanish
References: 38
Page: 959-967
PDF size: 212.40 Kb.

ABSTRACT

Background: Breast cancer represents the main neoplasia in incidence and mortality in women, it can be divided into molecular subtypes (luminal A, luminal B, HER2 and triple negative) having a differential prognosis and survival rates. There is literature that demonstrates the strong association between estrogenic stimulating factors and breast cancer, but the existing differences by molecular subtypes are not clear.
Objective: To review the recent literature and describe the relationship found between molecular subtypes of breast cancer and estrogenic stimulating factors.
Methodology: Search in the PubMed and LILACS databases with the MeSH and DeCS terms: breast neoplasms, molecular subtypes, risk factors, reproductive factors, looking for the association between the antecedents of parity, age at first pregnancy and history of breastfeeding with molecular subtypes of breast cancer (luminal A, luminal B and HER2).
Results: A total of 366 results were obtained, excluding 352 articles when evaluating duplicity, titles and abstracts, articles without relevance to the topic, research protocols and articles that did not study the association of estrogenic stimulating factors with molecular subtypes of breast cancer, resulting in 14 articles.
Conclusions: Hormone receptor-positive tumors were found to be associated with older age at first pregnancy, longer time between menarche and first term pregnancy and older age at last pregnancy. Breastfeeding and multiparity were found as protective factors for luminal tumors and pure Her2.

REFERENCES

1. Kellerman RD, KUSM-W Medical Practice Association.Conn’s Current Therapy 2020, E-Book. Elsevier HealthSciences, 2019; 1472. https://play.google.com/store/books/details?id=cyDCDwAAQBAJ

2. Torre LA, Bray F, Siegel RL, Ferlay J, et al. Global cancerstatistics, 2012. Vol. 65, CA: A Cancer Journal for Clinicians2015; 87-108. http://dx.doi.org/10.3322

3. World Health Organization, International Agency forResearch on Cancer. The Global Cancer Observatory.2020 statistics. https://gco.iarc.fr/today/data/factsheets/populations/900-world-fact-sheets.pdf

4. Coates AS, Winer EP, Goldhirsch A, Gelber RD, et al.Tailoring therapies--improving the management of earlybreast cancer: St Gallen International Expert Consensuson the Primary Therapy of Early Breast Cancer 2015. AnnOncol 2015; 26 (8): 1533-46. http://dx.doi.org/10.1093/annonc/mdv221

5. Amadou A, Torres-Mejía G, Hainaut P, Romieu I. Breastcancer in Latin America: global burden, patterns, and riskfactors. Salud Publica Mex 2014; 56 (5): 547-54. http://dx.doi.org/10.21149/spm.v56i5.7379

6. Villarreal-Garza C, Aguila C, Magallanes-Hoyos MC, MoharA, et al. Breast cancer in young women in Latin America: anunmet, growing burden. Oncologist 2013; 18 (12): 1298-306. http://dx.doi.org/10.1634/theoncologist.2013-0321

7. Ramírez-Martínez CM, Clavijo-Rodríguez JM, Estrada-Restrepo J, Restrepo-Ramírez CA. Descripción clínica,anatomopatológica y de tratamiento de pacientes concáncer de mama en una unidad de mastología de la ciudadde Medellín, Colombia. 2006- 2013. CES MEDICINA.2015;29 (2): 181-90. http://dx.doi.org/10.4321/s0378-48352006000100003

8. Hedeen AN, White E. Breast cancer size and stage inHispanic American women, by birthplace: 1992-1995.Am J Public Health 2001; 91 (1): 122-5. http://dx.doi.org/10.2105/ajph.91.1.122

9. Rakha EA, El-Rehim DA, Paish C, Green AR, et al. Basalphenotype identifies a poor prognostic subgroup of breastcancer of clinical importance. Eur J Cancer 2006; 42 (18):3149-56. http://dx.doi.org/10.1016/j.ejca.2006.08.015

10. Rakha E, El-Rehim A, Putti T, Lee A, et al. Breast carcinomaswith basal phenotype: An appraisal of morphology andprognostic significance. European J Cancer Suppl 2006;4:113. http://dx.doi.org/10.1016/s1359-6349(06)80246-6

11. Sørlie T, Perou CM, Tibshirani R, Aas T, et al. Gene expressionpatterns of breast carcinomas distinguish tumorsubclasses with clinical implications. Proc Natl Acad Sci US A 2001; 98 (19): 10869-74. http://dx.doi.org/10.1073/pnas.191367098

12. Forouzanfar MH, Foreman KJ, Delossantos AM, LozanoR, et al. Breast and cervical cancer in 187 countries between1980 and 2010: a systematic analysis. Lancet 2011;378 (9801): 1461-84. http://dx.doi.org/10.1016/S0140-6736(11)61351-2

13. Ramírez K, Acevedo F, Herrera ME, Ibáñez C, et al. Actividadfísica y cáncer de mama: un tratamiento dirigido.Revista médica de Chile. 2017; 145: 75-84. http://dx.doi.org/10.4067/s0034-98872017000100011

14. Wolin KY, Schwartz AL, Matthews CE, Courneya KS, et al.Implementing the exercise guidelines for cancer survivors.J Support Oncol 2012; 10 (5): 171-7. http://dx.doi.org/10.1016/j.suponc.2012.02.001

15. Shantakumar S, Terry MB, Teitelbaum SL, Britton JA, et al.Reproductive factors and breast cancer risk among olderwomen. Breast Cancer Res Treat 2007; 102 (3): 365-74.http://dx.doi.org/10.1007/s10549-006-9343-4

16. Rosner B, Colditz GA, Willett WC. 94144079 Reproductiverisk factors in a prospective study of breast cancer: Thenurses’ health study. Maturitas 1994; 20: 224. http://dx.doi.org/10.1016/0378-5122(94)90030-2

17. Romero FMS, Santillán AL, Olvera HPC, Morales SMA, etal. Frecuencia de factores de riesgo de cáncer de mama.Ginecol Obstet Mex 2008; 76 (11): 667-72.

18. Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factorsand breast cancer risk according to joint estrogen andprogesterone receptor status: a meta-analysis of epidemiologicalstudies. Breast Cancer Res 2006; 8 (4): R43. http://dx.doi.org/10.1186/bcr1525

19. Phipps AI, Malone KE, Porter PL, Daling JR, et al. Reproductiveand hormonal risk factors for postmenopausal luminal,HER-2-overexpressing, and triple-negative breast cancer.Cancer 2008; 113 (7): 1521-26. http://dx.doi.org/10.1002/cncr.23786

20. Ambrosone CB, Zirpoli G, Ruszczyk M, Shankar J, et al. Parityand breastfeeding among African-American women: differentialeffects on breast cancer risk by estrogen receptorstatus in the Women’s Circle of Health Study. Cancer CausesControl 2014; 25 (2): 259-65. http://dx.doi.org/10.1007/s10552-013-0323-9

21. Barnard ME, Boeke CE, Tamimi RM. Established breastcancer risk factors and risk of intrinsic tumor subtypes.Biochim Biophys Acta 2015; 1856 (1): 73-85. http://dx.doi.org/10.1016/j.bbcan.2015.06.002

22. Work ME, John EM, Andrulis IL, Knight JA, et al. Reproductiverisk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer FamilyRegistry. Br J Cancer 2014; 110 (5): 1367-77. http://dx.doi.org/10.1038/bjc.2013.807

23. Islami F, Liu Y, Jemal A, Zhou J, et al. Breastfeeding andbreast cancer risk by receptor status -a systematic reviewand meta-analysis. Annals of Oncology 2015; 26: 2398-407.http://dx.doi.org/10.1093/annonc/mdv379

24. Romieu I, Biessy C, Carayol M, His M, et al. Reproductivefactors and molecular subtypes of breast cancer amongpremenopausal women in Latin America: the PRECAMAstudy. Sci Rep 2018; 8 (1): 13109. http://dx.doi.org/10.1038/s41598-018-31393-7

25. Ellingjord-Dale M, Vos L, Tretli S, Hofvind S, et al. Parity,hormones and breast cancer subtypes -Results from alarge nested case-control study in a national screeningprogram. Breast Cancer Research 2017;19. http://dx.doi.org/10.1186/s13058-016-0798-x

26. Lambertini M, Santoro L, Del Mastro L, Nguyen B, et al. Reproductivebehaviors and risk of developing breast canceraccording to tumor subtype: A systematic review and metaanalysisof epidemiological studies. Cancer Treat Rev 2016;49: 65-76. http://dx.doi.org/10.1016/j.ctrv.2016.07.006

27. Li C, Fan Z, Lin X, Cao M, et al. Parity and risk of developingbreast cancer according to tumor subtype: A systematicreview and meta-analysis. Cancer Epidemiol 2021; 75:102050. http://dx.doi.org/10.1016/j.canep.2021.102050

28. Wang JM, Wang J, Zhao HG, Liu TT, et al. ReproductiveRisk Factors Associated with Breast Cancer MolecularSubtypes among Young Women in Northern China.Biomed Res Int 2020; 2020: 5931529. http://dx.doi.org/10.1155/2020/5931529

29. Park S, Moon BI, Oh SJ, Lee H-B, et al. Clinical subtypes andprognosis in breast cancer according to parity: a nationwidestudy in Korean Breast Cancer Society. Breast Cancer ResTreat 2019; 173 (3): 679-91. http://dx.doi.org/10.1007/s10549-018-5032-3

30. Figueroa JD, Davis Lynn BC, Edusei L, Titiloye N, et al.Reproductive factors and risk of breast cancer by tumorsubtypes among Ghanaian women: A population-basedcase-control study. Int J Cancer 2020; 147 (6): 1535-47.http://dx.doi.org/10.1002/ijc.32929

31. Minami Y, Nishino Y, Kawai M, Tada H, et al. Reproductivehistory and breast cancer survival: a prospective patientcohort study in Japan. Breast Cancer 2019; 26 (6): 687-702.http://dx.doi.org/10.1007/s12282-019-00972-5

32. von Au A, Klotzbuecher M, Uhlmann L, Boudewijns M, et al.Impact of reproductive factors on breast cancer subtypesin postmenopausal women: a retrospective single-centerstudy. Arch Gynecol Obstet 2017; 295 (4): 971-8. http://dx.doi.org/10.1007/s00404-017-4298-8

33. Xing P, Li J, Jin F. A case-control study of reproductive factorsassociated with subtypes of breast cancer in NortheastChina. Med Oncol 2010; 27 (3): 926-31. http://dx.doi.org/10.1007/s12032-009-9308-7

34. Li H, Sun X, Miller E, Wang Q, et al. BMI, reproductive factors,and breast cancer molecular subtypes: A case-controlstudy and meta-analysis. J Epidemiol 2017; 27 (4): 143-51.http://dx.doi.org/10.1016/j.je.2016.05.002

35. Zhang L, Huang Y, Feng Z, Wang X, et al. Comparison ofbreast cancer risk factors among molecular subtypes: Acase-only study. Cancer Med 2019; 8 (4): 1882-92. http://dx.doi.org/10.1002/cam4.2012

36. Arteaga-Gómez AC, Zapata-Caballero CA, Arellano-EguiluzA, Santoyo-Rosas SE, et al. Terapia hormonal de reemplazoy riesgo de cáncer ginecológico en mujeres en el climaterio.Revisión narrativa. Ginecol Obstet Mex 2021; 89 (6): 464-71. https://doi.org/10.24245/gom. v89i6.5189

37. Alarcón Rojas CA, Alvarez-Bañuelos MT, Morales-Romero J,Suárez-Díaz H, et al. Breast Cancer: Metastasis, MolecularSubtypes, and Overweight and Obesity in Veracruz, Mexico.Clin Breast Cancer 2019; 19 (1): e166-71. http://dx.doi.org/10.1016/j.clbc.2018.08.003

38. Lope V, García-Esquinas E, Pérez-Gómez B, Altzibar JM, etal. Perinatal and childhood factors and risk of breast cancersubtypes in adulthood. Cancer Epidemiol 2016; 40: 22-30.http://dx.doi.org/10.1016/j.canep.2015.11.004.